🇺🇸 FDA
Pipeline program

VYEPTI 100 mg concentrate for solution for infusion

RESOLUTION 20007A

Approved small_molecule active

Quick answer

VYEPTI 100 mg concentrate for solution for infusion for Chronic Migrane, Migrane, Medication Overuse Headache is a Approved program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
H. Lundbeck A/S
Indication
Chronic Migrane, Migrane, Medication Overuse Headache
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials